Manageable LeverageLow-to-moderate debt (D/E ~0.18–0.20) gives CirChem a structural cushion versus highly leveraged peers. This reduces short-term default risk and preserves capacity to raise financing or absorb temporary losses, supporting operational continuity over the next several months.

Sustainable, Diversified Business ModelCirChem's multi-channel sales, distributor/partner network, and R&D-driven proprietary formulations create durable commercial pathways. The sustainability focus attracts grants and strategic partners, helping stabilize non-dilutive funding and supporting demand persistence in end markets.

Proven Near Break-even ExecutionHaving approached operating break-even in 2024 indicates management can compress costs and scale operations toward profitability. This operational leverage suggests a realistic pathway to restore margins if revenue stabilizes, making recovery more plausible over a 2-6 month horizon.

Bears Say

Sharp Revenue DeclineA near 30% YoY revenue drop materially weakens scale and market traction. Reduced top-line volume impairs fixed-cost absorption, undermines pricing power and distributor confidence, and lengthens the recovery timeline for restoring margins and cash generation.

Large Operating And Net LossesSubstantial operating and net losses erode equity and limit reinvestment capacity. Persistent negative margins indicate structural profitability issues rather than one-off items, increasing the likelihood of continued support needs or strategic retrenchment to restore financial health.

Material Negative Cash FlowSustained negative operating and free cash flows create an ongoing funding requirement. Even with low leverage, continued cash burn forces reliance on equity raises, grants or external financing, which can dilute shareholders or constrain strategic investments over the medium term.

CIRCHE FAQ

What was CirChem AB’s price range in the past 12 months?

CirChem AB lowest stock price was kr0.60 and its highest was kr3.59 in the past 12 months.

What is CirChem AB’s market cap?

CirChem AB’s market cap is kr44.83M.

When is CirChem AB’s upcoming earnings report date?

CirChem AB’s upcoming earnings report date is May 19, 2026 which is in 87 days.

How were CirChem AB’s earnings last quarter?

CirChem AB released its earnings results on Feb 18, 2026. The company reported -kr0.117 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.117.

Is CirChem AB overvalued?

According to Wall Street analysts CirChem AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does CirChem AB pay dividends?

CirChem AB does not currently pay dividends.

What is CirChem AB’s EPS estimate?

CirChem AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does CirChem AB have?

CirChem AB has 40,205,837 shares outstanding.

What happened to CirChem AB’s price movement after its last earnings report?

CirChem AB reported an EPS of -kr0.117 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -13.23%.

Which hedge fund is a major shareholder of CirChem AB?

Currently, no hedge funds are holding shares in SE:CIRCHE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

CirChem AB

CirChem AB (publ) engages in recycling of used solvents in Sweden. It collects and purify used industrial solvents for reuse; and produces other chemical products, such as washer fluid and rubbing alcohol. CirChem AB (publ)was founded in 2013 and is based in Vargon, Sweden.